Skip to main content
. Author manuscript; available in PMC: 2019 Sep 1.
Published in final edited form as: Anticancer Drugs. 2018 Sep;29(8):717–724. doi: 10.1097/CAD.0000000000000652

Figure 1. Expression of GSK-3β in human neuroblastoma.

Figure 1

(a–d) Representative pictures of GSK-3β expression in human neuroblastoma. GSK-3β is overexpressed in cancer cells in human neuroblastoma tumors obtained from two cancer patients (a, b) and in xenograft tumors established from SK-N-BE(2) and SK-N-DZ neuroblastoma cell lines (c, d).